Gene therapy for intraperitoneally disseminated pancreatic cancers by Escherichia coli uracil phosphoribosiltransferase (UPRT) gene mediated by restricted replication‐competent adenoviral vectors
Open Access
- 25 September 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 102 (1) , 51-59
- https://doi.org/10.1002/ijc.10650
Abstract
Although patients with unresectable pancreatic tumors have been treated with 5‐fluorouracil (5FU)‐based combination chemotherapy, the drug resistance of cancer cells presents a crucial therapeutic problem. It was reported that UPRT overcomes 5FU resistance. UPRT catalyzes the synthesis of 5‐fluorouridine monophosphate (FUMP) from Uracil and phosphoribosylpyrophosphate (PRPP). The antitumor effect of 5FU is enhanced by augmenting 5‐fluorodeoxyuridine monophosphate (FdUMP) converted from FUMP, which inhibits thymidylate synthetase (TS). We first demonstrated that injecting an E1‐deficient adenoviral vector (Adv) expressing UPRT (AxCAUPRT) followed by 5‐FU treatment resulted in a volume reduction of xenotransplanted human tumors. In examining the therapeutic effect of AxCAUPRT/5‐FU against peritoneal dissemination, we found that non‐selective gene transduction of AxCAUPRT caused severe adverse effects arising from the increase of F‐dUMP in normal intestine. Because the therapeutic gene delivered by a restricted replication‐competent Adv lacking 55 kDa E1B protein (AxE1AdB) is speculated to be expressed selectively in tumors, mice with established tumors were injected with AxE1AdB and E1‐deleted Adv expressing the lacZ reporter gene (AxCAlacZ). The expression of the reporter gene (lacZ) was selectively enhanced in disseminated tumors. The therapeutic advantage of restricted replication competent Adv that expresses UPRT (AxE1AdB‐UPRT) was evaluated in an intraperitoneal disseminated tumor model. To study the anti‐tumor effect of AxE1AdB‐UPRT/5FU, mice with disseminated AsPC‐1 tumors were administered the Adv, followed by the 5FU treatment. It was shown that the treatment with AxE1AdB‐UPRT/5FU caused a dramatic reduction of the disseminated tumor burden without toxicity in normal tissues. Our results showed that the AxE1AdB‐UPRT/5FU system is a promising tool for intraperitoneal disseminated pancreatic cancer.Keywords
This publication has 24 references indexed in Scilit:
- Gene delivery from replication-selective viruses: arming guided missiles in the war against cancerJournal of Clinical Investigation, 2000
- Effective Gene Therapy for Pancreatic Cancer by Cytokines Mediated by Restricted Replication-Competent AdenovirusHuman Gene Therapy, 2000
- Circumvention of 5‐Fluorouracil Resistance in Human Stomach Cancer Cells by Uracil Phosphoribosyltransferase Gene TransductionJapanese Journal of Cancer Research, 1999
- Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancerGene Therapy, 1999
- Treatment of Advanced Pancreatic Adenocarcinoma with 5-FU, Leucovorin, Interferon-α-2b, and CisplatinAmerican Journal of Clinical Oncology, 1997
- Detection of single-copy genes in DNA from transgenic plants by nonradioactive Southern blot analysisMolecular Biotechnology, 1997
- Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectorsGastroenterology, 1996
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Gene Therapy for α–Fetoprotein–Producing Human Hepatoma Cells by Adenovirus–Mediated Transfer of the Herpes Simplex Virus Thymidine Kinase GeneHepatology, 1996
- Establishment of a human pancreatic cancer cell line and detection of pancreatic cancer associated antigen.The Tohoku Journal of Experimental Medicine, 1984